Results 121 to 130 of about 4,744 (194)

Allelic Variants of the <i>DPYD</i> Gene in Russian Patients with Cancer: The Results of Exome Sequencing. [PDF]

Genes (Basel)
Fedorinov D, Lyadov V, Lyadova M, Abdullaev S, Sychev I, Filatova A, Danilov L, Glotov O, Budagova I, Mirzaev K, Sychev D.   +10 more
europepmc   +1 more source

Dihydropyrimidine dehydrogenase modulates immune response to checkpoint inhibition in mismatch repair deficient/microsatellite instability-high colorectal cancer. [PDF]

J Immunother Cancer
Soni S, Battaglin F, Castanon S, Yang Y, Smbatyan G, Torres Gonzalez L, Ho Lo J, Mittal P, Gonzalez E, Baugh AG, Soto Trujillo S, Ashouri K, Algaze S, Jayachandran P, Zhang W, K Singh I, Cerma K, Bergamo F, Lonardi S, Zhang Y, Kay SA, Yu J, Zhang L, Millstein J, T Roussos Torres E, Lenz HJ.   +25 more
europepmc   +1 more source

Identification of a large <i>DPYD</i> gene deletion undetected by standard genotyping in a patient with severe capecitabine-related toxicity: a case report. [PDF]

Front Pharmacol
Delcuratolo MD, Rodriquenz MG, Morelli F, Latiano TP, Muscarella LA, Caporilli S, Pasqualini L, De Santis E, Giambra V, Rinaldi A, Ciavarella G, Floris M, Murru R, Mascia A, De Mattia E, Canil G, Fania G, Pop A, Carella M, van Kuilenburg A, Cecchin E, Miscio G.   +21 more
europepmc   +1 more source

A rare variant in DPYD c.812delT causes severe adverse events of S-1 in a patient with tongue cancer. [PDF]

Cancer Chemother Pharmacol
Ishimura H, Suehiro A, Hira D, Hishinuma E, Kato M, Maekawa M, Yasuda T, Katsube Y, Katada Y, Imayoshi N, Shigetsura Y, Nakagawa S, Tsuda M, Hiratsuka M, Terada T.   +14 more
europepmc   +1 more source

<i>DPYD</i>-Guided Dosing of Metronomic Capecitabine Plus Vinorelbine in Metastatic Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Real-World Retrospective Study. [PDF]

JCO Precis Oncol
Schettini F, Membrino A, Di Grazia G, Caltavituro A, Strina C, Milani M, Impeduglia A, Paganini L, Bosi A, Tedoldi S, Gatti M, Cervoni V, Alberio M, Giuliano M, Venturini S, Generali D.   +15 more
europepmc   +1 more source

Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A <i>DPYD</i> Variant Allele. [PDF]

JCO Precis Oncol
Heersche N, Knikman JE, Deenen MJ, Rosing H, van Schaik RHN, Beijnen JH, Schellens JHM, Gelderblom H, Guchelaar HJ, Swen JJ, Cats A, Mathijssen RHJ, Jacobs BAW.   +12 more
europepmc   +1 more source

Fatal 5-Fluorouracil Toxicity With Hyperammonemic Encephalopathy, Lactic Acidosis, and Pneumatosis Intestinalis Despite Uridine Triacetate Rescue: A Case Report. [PDF]

Cureus
Matar H, Sembroski E, Buzard B, Shewmaker J, Blunck JR.   +4 more
europepmc   +1 more source

Cost-effectiveness of DPYD genotyping prior to capecitabine administration for metastatic breast cancer. [PDF]

Breast Cancer Res Treat
Chiddarwar T, Blaes A, Kuntz K.
europepmc   +1 more source

Genotyping of DPYD and UGT1A1 in Brazilian oncological patients: applying pharmacogenomics in an admixed population. [PDF]

Rev Assoc Med Bras (1992)
Cereser VHB, Moniz CMV, Suarez-Kurtz G, Estevez-Diz MDP.   +3 more
europepmc   +1 more source

UGT1A1 and irinotecan: Ready for routine pharmacogenetic care. [PDF]

Br J Clin Pharmacol
Swen JJ.
europepmc   +1 more source